Myelosuppression-associated side effects; n = 60
Adverse event . | No. . | % . |
|---|---|---|
| Prolonged myelosuppression*; grade 3 or higher | ||
| Anemia | 19 | 32 |
| Neutropenia | 26 | 43 |
| Thrombocytopenia | 25 | 42 |
| Infections | ||
| FUO | 38 | 63 |
| Documented infections | ||
| Pneumonia | 23 | 38 |
| Septicemia | 20 | 33 |
| Skin | 8 | 13 |
| Urine | 5 | 8 |
| Sinus | 2 | 3 |
| Stool; C difficile | 2 | 3 |
Adverse event . | No. . | % . |
|---|---|---|
| Prolonged myelosuppression*; grade 3 or higher | ||
| Anemia | 19 | 32 |
| Neutropenia | 26 | 43 |
| Thrombocytopenia | 25 | 42 |
| Infections | ||
| FUO | 38 | 63 |
| Documented infections | ||
| Pneumonia | 23 | 38 |
| Septicemia | 20 | 33 |
| Skin | 8 | 13 |
| Urine | 5 | 8 |
| Sinus | 2 | 3 |
| Stool; C difficile | 2 | 3 |
Blood count recovery exceeding 42 days from start of therapy.